Jean-François Pujol
Hoofd Techniek/Wetenschap/O&O bij Biocortech SAS
Profiel
Jean-François Pujol co-founded Biocortech AS and serves as Chief Scientific Officer.
He is a Professor at the Laennec Medical School.
Previously, he was Head of CNS Department for Roussel Uclaf (now Sanofi-Aventis).
He has been a Member of the Board of Directors at University of Lyon, the Neuroscience Fed Institute, Liège Cyclotron.
Dr. Pujol received an MD and a PhD from the Lyon University.
Actieve functies van Jean-François Pujol
| Bedrijven | Functie | Begin |
|---|---|---|
Biocortech SAS
 Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Jean-François Pujol
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Lyon | Corporate Officer/Principal | - |
| Roussel Uclaf SA | Corporate Officer/Principal | - |
Opleiding van Jean-François Pujol
| Ecole Centrale Lyon | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Biocortech SAS
Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France. | Health Technology |
| Roussel Uclaf SA | Health Technology |
